Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study

BACKGROUND: Clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 (PD-1) remain unknown. OBJECTIVE: To better characterize the occurrence of vitiligo in patients receiving anti–PD-1. METHODS: The present single-center ambispective cohort study included patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Dousset, Léa, Pacaud, Alize, Barnetche, Thomas, Kostine, Marie, Dutriaux, Caroline, Pham-Ledard, Anne, Beylot-Barry, Marie, Gérard, Emilie, Prey, Sorilla, Andreu, Nicolas, Boniface, Katia, Seneschal, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529074/
https://www.ncbi.nlm.nih.gov/pubmed/34712997
http://dx.doi.org/10.1016/j.jdin.2021.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529074/
https://www.ncbi.nlm.nih.gov/pubmed/34712997
http://dx.doi.org/10.1016/j.jdin.2021.09.002

Ejemplares similares